Living with mastectomy and breast conservation treatment: who suffers more?
Ohad Gilbar(University of Haifa), Emilie C. Robinson(University of Haifa), Miri Cohen(University of Haifa), Georgeta Fried(Roche (Switzerland)), Y. Taller(IMI TAMI Institute for Research and Development), László Ungár(Unified Szent István and Szent László Hospital)
Cited by 11
Related Papers
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
|Gynecologic Oncology|2015|301
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
|npj Breast Cancer|2017|87
Comparing Relaxation Training and Cognitive-Behavioral Group Therapy for Women With Breast Cancer
|Research on Social Work Practice|2007|82